@article{article, title  = {{Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},

 publisher = {{Springer Verlag}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/128751 }},

 year = {{2018}},

 month = {{9}},

 author = {{Uttley L and Bermejo I and Ren S and Martyn-St James M and Wong R and Scott DL and Young A and Stevenson M}},

 doi = {{10.1007/s40273-018-0639-0}},

 volume = {{36}},

 journal = {{Pharmacoeconomics}},

 issue = {{9}},

 pages = {{1063-1072}},

 note = {{Accessed on 2025/11/02}}}